RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Merck & Company Incorporated

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Top Merck & Company Incorporated Articles

Displaying items 13-24
  • U.S. approves Merck immune-stimulating drug for melanoma

    (Reuters) - U.S. regulators on Thursday approved the use of Merck & Co Inc's immuno-oncology drug Keytruda, also known as pembrolizumab, as a treatment for patients with advanced melanoma who are no longer responding to other therapies. The decision...
  • Google's health firm Calico announces massive investment in treatments for the elderly

    MOUNTAIN VIEW, Calif. In its first major step since its formation last year, Google's life-science spin-off on Wednesday announced a partnership with drug-giant AbbVie to build a "world-class research and development" facility in the Bay Area and spend up...
  • Zoetis granted conditional license by USDA for PEDv vaccine

    CHICAGO (Reuters) - Zoetis Inc has received a conditional license from the U.S. Department of Agriculture for its vaccine against a deadly piglet virus and will begin selling it this month in the United States, the company said on Wednesday. Shares of...
  • South Korea lifts ban on beef with feed additive: food ministry

    SEOUL (Reuters) - South Korea has lifted a ban on the use of animal feed additive zilpaterol in beef, opening the door to imports containing the growth enhancer as well as domestic sales of the product. Seoul said last October that it intended to ease...
  • AstraZeneca boosted by start of new cancer drug trial

    LONDON (Reuters) - Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer. The drug, which is designed to help the...
  • Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

    (Reuters) - Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S....
  • Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...
  • EU regulator warns on possible MS drugs side effects

    FRANKFURT (Reuters) - Europe's drug safety regulator said multiple sclerosis treatments known as interferon beta need stronger label warnings because some patients treated with the drugs have suffered side effects affecting the kidney and other organs. A...
  • P&G eyes Duracell, Braun in sweeping brand culling: sources

    NEW YORK (Reuters) - Procter & Gamble Co is working with advisors including Goldman Sachs Group as the world's largest household products maker reviews up to 100 underperforming brands for potential divestiture, people familiar with the matter said....
  • 'Plantibodies' drugs advance as big pharma stands aside

    LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies. The leading...
  • Achillion's hepatitis C drug shows promise in trial

    (Reuters) - Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent. The mid-stage trial tested Achillion's...
  • FDA approves Belsomra, a new prescription sleep drug

    FDA approves Belsomra, a new prescription sleep drug
    The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the...